2022-08-01 2023-07-31 false Capium Accounts Production 1.1 06949171 bus:FullAccounts 2022-08-01 2023-07-31 06949171 bus:FRS102 2022-08-01 2023-07-31 06949171 bus:AuditExempt-NoAccountantsReport 2022-08-01 2023-07-31 06949171 bus:SmallCompaniesRegimeForAccounts 2022-08-01 2023-07-31 06949171 bus:PrivateLimitedCompanyLtd 2022-08-01 2023-07-31 06949171 2022-08-01 2023-07-31 06949171 2023-07-31 06949171 bus:RegisteredOffice 2022-08-01 2023-07-31 06949171 core:WithinOneYear 2023-07-31 06949171 core:AfterOneYear 2023-07-31 06949171 bus:Director1 2022-08-01 2023-07-31 06949171 bus:Director1 2023-07-31 06949171 bus:Director1 2021-08-01 2022-07-31 06949171 2021-08-01 06949171 bus:CompanySecretary1 2022-08-01 2023-07-31 06949171 bus:LeadAgentIfApplicable 2022-08-01 2023-07-31 06949171 2021-08-01 2022-07-31 06949171 2022-07-31 06949171 core:WithinOneYear 2022-07-31 06949171 core:AfterOneYear 2022-07-31 06949171 bus:EntityAccountantsOrAuditors 2021-08-01 2022-07-31 06949171 bus:OrdinaryShareClass1 2022-08-01 2023-07-31 06949171 bus:OrdinaryShareClass1 2023-07-31 06949171 bus:OrdinaryShareClass1 2021-08-01 2022-07-31 06949171 bus:OrdinaryShareClass1 2022-07-31 06949171 core:PlantMachinery 2022-08-01 2023-07-31 06949171 core:PlantMachinery 2023-07-31 06949171 core:PlantMachinery 2022-07-31 06949171 core:ComputerEquipment 2022-08-01 2023-07-31 06949171 core:ComputerEquipment 2023-07-31 06949171 core:ComputerEquipment 2022-07-31 06949171 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-07-31 06949171 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2022-07-31 06949171 core:NetGoodwill 2022-08-01 2023-07-31 06949171 core:NetGoodwill 2023-07-31 06949171 core:NetGoodwill 2022-07-31 06949171 core:CostValuation core:Non-currentFinancialInstruments 2023-07-31 06949171 core:CostValuation core:Non-currentFinancialInstruments 2022-07-31 06949171 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2023-07-31 06949171 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2023-07-31 06949171 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2023-07-31 06949171 core:Non-currentFinancialInstruments 2023-07-31 06949171 core:Non-currentFinancialInstruments 2022-07-31 06949171 core:ShareCapital 2023-07-31 06949171 core:ShareCapital 2022-07-31 06949171 core:RetainedEarningsAccumulatedLosses 2023-07-31 06949171 core:RetainedEarningsAccumulatedLosses 2022-07-31 06949171 dpl:Item1 2022-08-01 06949171 dpl:Item1 2023-07-31 06949171 dpl:Item1 2021-08-01 06949171 dpl:Item1 2022-07-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 06949171
England and Wales

 

 

 

SHIRAZ PHARM LIMITED


Unaudited Financial Statements
 


Period of accounts

Start date: 01 August 2022

End date: 31 July 2023
Director Mr Shiraz Mohammed Mirza
Registered Number 06949171
Registered Office 30 The Pastures
Beardwood
Blackburn
BB2 7QR
1
 
 
Notes
 
2023
£
  2022
£
Fixed assets      
Tangible fixed assets 4 1,052    140 
1,052    140 
Current assets      
Debtors 5 4,049    5,849 
Cash at bank and in hand 54,550    55,368 
58,599    61,217 
Creditors: amount falling due within one year 6 (35,306)   (39,778)
Net current assets 23,293    21,439 
 
Total assets less current liabilities 24,345    21,579 
Net assets 24,345    21,579 
 

Capital and reserves
     
Called up share capital 7 1    1 
Profit and loss account 24,344    21,578 
Shareholder's funds 24,345    21,579 
 


For the year ended 31 July 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the director on 18 April 2024 and were signed by:


-------------------------------
Mr Shiraz Mohammed Mirza
Director
2
General Information
Shiraz Pharm Limited is a private company, limited by shares, registered in England and Wales, registration number 06949171, registration address 30 The Pastures, Beardwood, Blackburn, BB2 7QR.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by Section 1A of the standard)
Turnover
Turnover comprises of invoiced value of goods and services supplied by the company.
Intangible assets
Intangible assets (including purchased goodwill and patents) are amortised at rates calculated to write off the assets on a straight line basis over their estimated useful economic lives. Impairment of intangible assets is only reviewed where circumstances indicate that the carrying value of an asset may not be fully recoverable.
Goodwill
Acquired goodwill is stated at cost less amortisation. Amortisation is calculated on a straight line basis over the estimated expected useful economic life of the goodwill of 5 years.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Plant and Machinery 15% Reducing Balance
Computer Equipment 3 Years Straight Line
2.

Average number of employees

Average number of employees during the year was 1 (2022 : 1).
3.

Intangible fixed assets

Cost Goodwill   Total
  £   £
At 01 August 2022 10,500    10,500 
Additions  
Disposals  
At 31 July 2023 10,500    10,500 
Amortisation
At 01 August 2022 10,500    10,500 
Charge for year  
On disposals  
At 31 July 2023 10,500    10,500 
Net book values
At 31 July 2023  
At 31 July 2022  


4.

Tangible fixed assets

Cost or valuation Plant and Machinery   Computer Equipment   Total
  £   £   £
At 01 August 2022 675      675 
Additions   1,119    1,119 
Disposals    
At 31 July 2023 675    1,119    1,794 
Depreciation
At 01 August 2022 535      535 
Charge for year 21    186    207 
On disposals    
At 31 July 2023 556    186    742 
Net book values
Closing balance as at 31 July 2023 119    933    1,052 
Opening balance as at 01 August 2022 140      140 


5.

Debtors: amounts falling due within one year

2023
£
  2022
£
Other Debtors 4,049    5,849 
4,049    5,849 

6.

Creditors: amount falling due within one year

2023
£
  2022
£
Trade Creditors   8,800 
Bank Loan - BBL 8,770    11,776 
Corporation Tax 1,139    862 
Accrued Expenses   900 
Director's Current Accounts 25,397    17,440 
35,306    39,778 

7.

Share Capital

Allotted, called up and fully paid
2023
£
  2022
£
1 Ordinary share of £1.00 each  
 

3